Cao L, Kagan J
Immunity. 2023; 56(10):2206-2217.
PMID: 37703879
PMC: 10591974.
DOI: 10.1016/j.immuni.2023.07.018.
Muller C, Knoflach P, Zielinski C
Dig Dis Sci. 1993; 38(3):477-81.
PMID: 8444079
DOI: 10.1007/BF01316502.
CRISPENS Jr C
Arch Virol. 1982; 72(1-2):67-74.
PMID: 6980638
DOI: 10.1007/BF01314451.
Granelli-Piperno A, Vassalli J, Reich E
J Exp Med. 1981; 154(2):422-31.
PMID: 6973604
PMC: 2186437.
DOI: 10.1084/jem.154.2.422.
Rifas L, Shen V, Mitchell K, Peck W
Proc Natl Acad Sci U S A. 1984; 81(14):4558-62.
PMID: 6611552
PMC: 345630.
DOI: 10.1073/pnas.81.14.4558.
Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.
Yamasaki T, Handa H, Yamashita J, Watanabe Y, Namba Y, Hanaoka M
Neurosurg Rev. 1984; 7(1):37-54.
PMID: 6611523
DOI: 10.1007/BF01743289.
Purification and partial biochemical characterization of normal human interleukin 1.
Schmidt J
J Exp Med. 1984; 160(3):772-87.
PMID: 6332170
PMC: 2187399.
DOI: 10.1084/jem.160.3.772.
Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).
Mizel S, Dayer J, Krane S, Mergenhagen S
Proc Natl Acad Sci U S A. 1981; 78(4):2474-7.
PMID: 6264478
PMC: 319369.
DOI: 10.1073/pnas.78.4.2474.
In vitro production of immunosuppressive factors by murine sarcoma virus-transformed mouse fibroblasts.
Mizel S, DeLarco J, Todaro G, Farrar W, Hilfiker M
Proc Natl Acad Sci U S A. 1980; 77(4):2205-8.
PMID: 6246526
PMC: 348681.
DOI: 10.1073/pnas.77.4.2205.
Functional consequences of perceived interleukin deficiencies? Analysis employing NZB x C58 recombinant inbred mice.
Bocchieri M, Smith Jr J, Smith J, Staruch M, Wood D
Clin Exp Immunol. 1985; 62(3):622-9.
PMID: 3878752
PMC: 1577467.
Amino acid sequence analysis of human interleukin 1 (IL-1). Evidence for biochemically distinct forms of IL-1.
Cameron P, Limjuco G, Rodkey J, Bennett C, Schmidt J
J Exp Med. 1985; 162(3):790-801.
PMID: 3875682
PMC: 2187801.
DOI: 10.1084/jem.162.3.790.
Human interleukin 1. Purification to homogeneity.
Kronheim S, March C, Erb S, Conlon P, Mochizuki D, Hopp T
J Exp Med. 1985; 161(3):490-502.
PMID: 3871836
PMC: 2187574.
DOI: 10.1084/jem.161.3.490.
Effects of a human urinary mitogen on subpopulations of peripheral blood mononuclear leukocytes.
WANGEL A, Kayhko K, Reitamo S, Jokinen I
Clin Exp Immunol. 1986; 66(1):248-53.
PMID: 3492317
PMC: 1542655.
Interleukin 2 defect in the peripheral blood and the lung in patients with Sjögren's syndrome.
Miyasaka N, Murota N, Yamaoka K, Sato K, Yamada T, Nishido T
Clin Exp Immunol. 1986; 65(3):497-505.
PMID: 3490935
PMC: 1542504.
Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells.
Bagby Jr G, Dinarello C, Wallace P, Wagner C, Hefeneider S, McCall E
J Clin Invest. 1986; 78(5):1316-23.
PMID: 3490494
PMC: 423824.
DOI: 10.1172/JCI112717.
Isolation and characterization of a primitive interleukin-1-like protein from an invertebrate, Asterias forbesi.
Beck G, Habicht G
Proc Natl Acad Sci U S A. 1986; 83(19):7429-33.
PMID: 3489938
PMC: 386731.
DOI: 10.1073/pnas.83.19.7429.
Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1.
Cameron P, Limjuco G, Chin J, Silberstein L, Schmidt J
J Exp Med. 1986; 164(1):237-50.
PMID: 3487613
PMC: 2188208.
DOI: 10.1084/jem.164.1.237.
Suppression of murine macrophage interleukin-1 release by the polysaccharide portion of Haemophilus actinomycetemcomitans lipopolysaccharide.
Nishihara T, Koga T, Hamada S
Infect Immun. 1988; 56(3):619-25.
PMID: 3257748
PMC: 259336.
DOI: 10.1128/iai.56.3.619-625.1988.
Immunoregulatory circuits in the acquired immune deficiency syndrome and related complex. Production of and response to interleukins 1 and 2, NK function and its enhancement by interleukin-2 and kinetics of the autologous mixed lymphocyte reaction.
Alcocer-Varela J, Alarcon-Segovia D, Abud-Mendoza C
Clin Exp Immunol. 1985; 60(1):31-8.
PMID: 3159524
PMC: 1576993.
Failure of exogenous interleukin 1 and interleukin 2 to correct decreased lymphocyte transformation in chronic hepatitis B virus carriers.
Anastassakos C, Alexander G, Wolstencroft R, Dumonde D, Eddleston A, Williams R
Clin Exp Immunol. 1987; 68(1):15-22.
PMID: 2958184
PMC: 1542683.